FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Asclemed USA Inc. dba Enovachem Pharmaceuticals Estriol Recall

Estriol, USP, (Micronized), 0

Asclemed USA Inc. dba Enovachem Pharmaceuticals · Torrance, CA

Risk level
Class II
Reported by FDA
Jan 15, 2020
Recall ID
D-0650-2020
Check your lot numberHow we source this data

Summary

Asclemed USA Inc. dba Enovachem Pharmaceuticals recalled Estriol starting Dec 9, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0650-2020 on Jan 15, 2020. Reason: Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.

Product description

Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36

Lot numbers, UPCs & expiration codes

Lot Code/Exp. Date: 11061901, 04011903, 04221904, 04241904, 06031902, 07301905, 09061903, EXP 12/31/2020

Where it was sold

Product was distributed to 6 physician's offices within the state of California.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0650-2020
Classification
Class II
Status
Terminated
Recall initiated
Dec 9, 2019
FDA report date
Jan 15, 2020
Quantity
8.52 gm
Recall type
Voluntary: Firm initiated
Recalling firm
Asclemed USA Inc. dba Enovachem Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0650-2020, exactly as published.

Show all FDA fields
City
Torrance
State
CA
Status
Terminated
Country
United States
Event ID
84550
Address
379 Van Ness Ave Ste 1403
Code information
Lot Code/Exp. Date: 11061901, 04011903, 04221904, 04241904, 06031902, 07301905, 09061903, EXP 12/31/2020
Postal code
90501-7211
Report date
Jan 15, 2020
Product type
Drugs
Recall number
D-0650-2020
Classification
Class II
Recalling firm
Asclemed USA Inc. dba Enovachem Pharmaceuticals
Product quantity
8.52 gm
Termination date
Aug 9, 2023
Reason for recall
Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36
Distribution pattern
Product was distributed to 6 physician's offices within the state of California.
Recall initiation date
Dec 9, 2019
Initial firm notification
Telephone
Center classification date
Jan 8, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0650-2020, published Jan 15, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls